- Home
- TSI vs TECH Comparison
TSI vs TECH Comparison
Compare TSI & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSI
- TECH
- Stock Information
- Founded
- TSI 1987
- TECH 1976
- Country
- TSI United States
- TECH United States
- Employees
- TSI N/A
- TECH 3100
- Industry
- TSI Investment Managers
- TECH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TSI Finance
- TECH Health Care
- Exchange
- TSI Nasdaq
- TECH Nasdaq
- Market Cap
- TSI 231.3M
- TECH 7.8B
- IPO Year
- TSI N/A
- TECH 1989
- Fundamental
- Price
- TSI $4.87
- TECH $49.69
- Analyst Decision
- TSI
- TECH Buy
- Analyst Count
- TSI 0
- TECH 8
- Target Price
- TSI N/A
- TECH $81.14
- AVG Volume (30 Days)
- TSI 106.8K
- TECH 2.3M
- Earning Date
- TSI 01-01-0001
- TECH 05-07-2025
- Dividend Yield
- TSI 7.46%
- TECH 0.63%
- EPS Growth
- TSI N/A
- TECH N/A
- EPS
- TSI N/A
- TECH 0.98
- Revenue
- TSI N/A
- TECH $1,196,016,000.00
- Revenue This Year
- TSI N/A
- TECH $8.19
- Revenue Next Year
- TSI N/A
- TECH $8.61
- P/E Ratio
- TSI N/A
- TECH $51.54
- Revenue Growth
- TSI N/A
- TECH 4.46
- 52 Week Low
- TSI $4.48
- TECH $46.44
- 52 Week High
- TSI $4.87
- TECH $85.57
- Technical
- Relative Strength Index (RSI)
- TSI 54.86
- TECH 41.82
- Support Level
- TSI $4.71
- TECH $49.15
- Resistance Level
- TSI $4.84
- TECH $51.53
- Average True Range (ATR)
- TSI 0.06
- TECH 2.64
- MACD
- TSI 0.01
- TECH 0.44
- Stochastic Oscillator
- TSI 85.00
- TECH 54.03
About TSI TCW Strategic Income Fund Inc.
Tcw Strategic Income Fund Inc operates as a closed-end management investment company. Its investment objective is to seek a total return comprised of current income and capital appreciation by investing in a wide range of securities. The company invests in a range of industries, such as airlines, banks, beverages, biotechnology, chemicals, computers, diversified financial services, entertainment and others.
About TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.